GPTHEALTH161.06

GPT Healthcare Limited

· Pharma & Health
₹ CrorePeersGKSLSHALBYINDRAMEDCOLOTUSEYEARTEMISMEDDRAGARWQKMCSHILKOVAIMcap ₹1,322 Cr
View
In ₹ Crore except Per Share
12 Months Ending
FY24
31/03/2024
FY25
31/03/2025
FY26
31/03/2026
Last 12M
30/06/2026
Adjustments to Reconcile Profit — Non-cash Items
+ Depreciation & Amortisation18.019.027.1
+ Finance Costs7.13.58.2
+ Interest Income-3.6-4.9-4.3
+ Fair Value (Gains) / Losses-0.20.0-0.5
+ Other Non-cash Items0.70.02.1
+ Other — Cash Effects are Investing / Financing0.00.01.3
+ Other Reconciling Items0.01.10.0
Changes in Working Capital
+ Inventories0.8-0.7-1.8
+ Trade Receivables — Current-5.4-0.1-3.5
+ Other Financial Assets — Current-7.80.00.0
+ Other Financial Assets — Non-current0.0-0.61.1
+ Other Current Assets0.00.00.0
+ Other Non-current Assets0.0-0.7-1.2
+ Trade Payables — Current4.5-2.47.2
+ Other Financial Liabilities — Current0.70.04.4
+ Other Financial Liabilities — Non-current0.00.50.0
+ Other Current Liabilities-1.20.00.4
+ Other Non-current Liabilities0.0-0.90.0
+ Provisions — Current2.30.0-1.2
+ Provisions — Non-current0.01.30.0
Cash from Operating Activities
Profit Before Tax (per I/S)68.069.354.860.9
+ Total Adjustments (incl. Working Capital)15.815.139.4
Cash from Operations (pre-tax)83.884.594.2
+ Income Taxes Paid15.017.113.0
Cash from Operating Activities68.867.481.2
Cash from Investing Activities
+ Acq of Fixed Assets (Capex)19.449.941.8
+ Disp of Fixed Assets0.20.51.0
+ Acq of Investment Property30.814.90.0
+ Disp of Investment Property14.213.70.0
+ Loans & Advances Repaid12.00.00.0
+ Interest Received — Investing3.95.02.9
+ Other Inflows / (Outflows) — Investing-5.313.1-9.3
Cash from Investing Activities-25.2-32.6-47.3
Cash from Financing Activities
+ Proceeds from Issue of Shares40.00.00.0
+ Buyback / Redemption of Own Shares2.50.00.0
+ Proceeds from Borrowings0.19.614.0
+ Repayment of Borrowings52.88.811.2
+ Payment of Lease Liabilities4.35.411.7
+ Interest Paid5.11.62.0
+ Dividends Paid24.028.720.5
Cash from Financing Activities-48.5-34.8-31.4
Net Changes in Cash (pre-FX)-4.9-0.02.5
Net Changes in Cash-4.9-0.02.5
Closing Cash1.7
Reference Items
EBITDA87.883.484.291.0
EBITDA Margin %21.9520.4817.8118.51
Free Cash Flow (CFO − Capex)49.417.539.339.3
Free Cash Flow to Equity16.840.1
Free Cash Flow per Basic Share6.022.134.794.79
Price to Free Cash Flow33.59
Cash Flow to Net Income1.441.351.92
Cash Paid for Taxes15.017.113.0
Cash Paid for Interest5.11.62.0
As filed, sign as filed: a payment tagged as a positive magnitude in the filing stays positive here, so read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown — depth follows the filer, so a thin statement means a thin filing. Total Adjustments is the filer's own grand total of the reconciliation and spans BOTH the non-cash items and the working-capital block; Profit Before Tax plus it equals Cash from Operations (pre-tax). It can be reported when its components are not, so it is never a sum of the rows above it. No consensus estimates → no Est columns. Click any row to chart it.
« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave
Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreementXBRL cross-verified ✓ 95%.